Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
24 Prestige Biopharma IDC CEO Sang-Seok Koh Receives Presidential Commendation
we******** | 2024.11.06 | Votes 0 | Views 188
we******** 2024.11.06 0 188
23 Prestige Biopharma IDC and Aptis Sign Collaboration for Next-Generation ADC Cancer Therapy Development
we******** | 2024.09.26 | Votes 0 | Views 191
we******** 2024.09.26 0 191
22 Prestige Biopharma Receives European Commission Approval for Herceptin Biosimilar Tuznue®
we******** | 2024.09.23 | Votes 0 | Views 270
we******** 2024.09.23 0 270
21 Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
김** | 2024.06.16 | Votes 0 | Views 391
김** 2024.06.16 0 391
20 Prestige Biopharma IDC Appoints Dr. Koh Sang-seok, Discoverer of PAUF Protein, as CEO
김** | 2024.03.05 | Votes 0 | Views 155
김** 2024.03.05 0 155
19 Prestige Biopharma Explores Global Expansion of PAUF-Based Pancreatic Cancer Diagnostic Kit at MEDICA 2023
we******** | 2023.11.16 | Votes 0 | Views 173
we******** 2023.11.16 0 173
18 Prestige Biopharma Secures Chinese Patent for PBP1510, a First-in-Class Anti-PAUF Antibody for Pancreatic Cancer
we******** | 2023.11.07 | Votes 0 | Views 215
we******** 2023.11.07 0 215
17 Prestige Biopharma Group Signs Strategic CDMO Partnership with Dr. Reddy’s Laboratories
김** | 2023.09.22 | Votes 0 | Views 323
김** 2023.09.22 0 323
16 Prestige Biopharma's Busan Innovative Drug Discovery Center (IDC) Designated as Advanced Investment Zone
김** | 2023.09.11 | Votes 0 | Views 193
김** 2023.09.11 0 193
15 Prestige Biopharma and Imagion Biosystems Sign an MOU, Developing Early Pancreatic Cancer Diagnosis Platform
김** | 2023.08.11 | Votes 0 | Views 219
김** 2023.08.11 0 219

Read Prestige news >>